Eva Martínez-Cáceres

5PUBLICATIONS
21CO-AUTHORS
Predictive and prognostic markersApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Behavioural epidemiologyHaematological tumoursMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Dec 09, 2024
SARS-CoV-2 Infection Risk by Vaccine Doses and Prior Infections Over 24 Months: ProHEpiC-19 Longitudinal Study.

Pere Torán-Monserrat, Noemí Lamonja-Vicente, Anna Costa-Garrido

|Aug 07, 2023
Challenges in tolerogenic dendritic cell therapy for autoimmune diseases: the route of administration.

María José Mansilla, Catharien M U Hilkens, Eva M Martínez-Cáceres

|Apr 28, 2023
Epstein-Barr Virus and Multiple Sclerosis: A Convoluted Interaction and the Opportunity to Unravel Predictive Biomarkers.

Oscar-Danilo Ortega-Hernandez, Eva M Martínez-Cáceres, Silvia Presas-Rodríguez

|Jan 21, 2022
Increased Natural Killer Cells Are Associated with Alcohol Liver Fibrosis and with T Cell and Cytotoxic Subpopulations Change.

Paola Zuluaga, Aina Teniente-Serra, Daniel Fuster

|Jul 24, 2021
Transfection of Vitamin D3-Induced Tolerogenic Dendritic Cells for the Silencing of Potential Tolerogenic Genes. Identification of CSF1R-CSF1 Signaling as a Glycolytic Regulator.

María José Mansilla, Iñigo González-Larreategui, Neus Figa-Martín

Pageof 1